Market Overview
Global Foot and Mouth Disease (FMD) Vaccines for Cattle market size was valued at USD
590 million in 2024. The market is projected to grow from USD 640 million in 2025 to USD 1,034 million by 2031, exhibiting a CAGR of 8.6% during the forecast period.
Foot and Mouth Disease (FMD) vaccines are biological preparations that provide immunity against the highly contagious FMD virus affecting cloven-hoofed animals. These vaccines primarily target cattle populations, though they're also used for pigs, sheep, and goats. The vaccines work by stimulating the animal's immune system to recognize and combat the virus, thereby preventing disease outbreaks that can devastate livestock industries.
USD 590 million in 2024
USD 1,034 million by 2031
CAGR of 8.6%
Inactivated Vaccine Segment Dominates the Market Due to its Proven Stability and Widespread Application in Routine Immunization Programs The market is segmented based on type into: Inactivated Vaccine Synthetic Peptide Vaccine
By Application
Conventional Vaccines Segment Leads Due to Extensive Use in Preventive Strategies Across Endemic Livestock Regions
The market is segmented based on application into:
Conventional Vaccines Emergency Vaccines
Portable Neuromonitoring Device Market
Our Key Players
Jinyu Group
Cavet Bio
CAHIC
Tecon Group
Shen Lian
BIGVET Biotech
https://www.24lifesciences.com/dow
https://www.24lifesciences.com
